Propofol anesthesia, seizure duration, and ECT: a case report and literature review.
Propofol is a nonbarbiturate anesthetic induction agent known to have anti-convulsant properties. When used as an anesthetic for electroconvulsive therapy (ECT), it can reduce seizure duration to a significant degree, which may not be fully appreciated. A case is presented in which propofol caused a 63.1% reduction in mean seizure duration compared with preceding and subsequent treatments with thiopental anesthesia. The literature on the use of propofol for ECT was reviewed with specific reference to its effect on seizure duration and any evidence of superiority to the barbiturate induction agents. It is concluded that propofol may have only very circumscribed indications as an anesthetic for ECT. If used, psychiatrists and anesthetists must be aware of its potency as an anticonvulsant.
Martin
B A
BA
ECT Service, Clarke Institute of Psychiatry, Toronto, Ontario, Canada.
Cooper
R M
RM
Parikh
S V
SV
D000328:Adult; D000758:Anesthesia; D004565:Electroconvulsive Therapy; D006801:Humans; D006993:Hypnotics and Sedatives; D008297:Male; D019964:Mood Disorders / Q000628:therapy; D015742:Propofol
D006993:Hypnotics and Sedatives; D015742:Propofol